Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Muscle glycogenoses.

S DiMauro1, C Lamperti

  • 1Department of Neurology, Columbia University College of Physicians and Surgeons, 4-420 College of Physicians and Surgeons, 630 West 168th Street, New York, NY 10032, USA. sd12@columbia.edu

Muscle & Nerve
|July 6, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary mitochondrial myopathy: 12-month follow-up results of an Italian cohort.

Journal of neurology·2022
Same author

Adult-onset mitochondrial movement disorders: a national picture from the Italian Network.

Journal of neurology·2021
Same author

AAV9-based gene therapy partially ameliorates the clinical phenotype of a mouse model of Leigh syndrome.

Gene therapy·2017
Same author

Revisiting mitochondrial ocular myopathies: a study from the Italian Network.

Journal of neurology·2017
Same author

Cerebellar ataxia and severe muscle CoQ10 deficiency in a patient with a novel mutation in ADCK3.

Clinical genetics·2016
Same author

Impact commentaries. Subacute necrotising encephalomyelopathy (Leigh's disease; Leigh syndrome).

Journal of neurology, neurosurgery, and psychiatry·2015
Same journal

Join AANEM.

Muscle & nerve·2026
Same journal

Targeted Muscle Reinnervation for Management and Prevention of Symptomatic Neuroma.

Muscle & nerve·2026
Same journal

AANEM News & Insights.

Muscle & nerve·2026
Same journal

Fat-Fraction Quantification Using Three-Point Dixon Technique in Duchenne Muscular Dystrophy and Its Correlation With Clinical Progression and Genotypic Characteristics: A Single Centre One-Year Prospective Study.

Muscle & nerve·2026
Same journal

Characterizing Combined Central and Peripheral Demyelination-Insights From a Multimodal Comparison With Chronic Inflammatory Demyelinating Polyneuropathy and Multiple Sclerosis.

Muscle & nerve·2026
Same journal

Electrical Modalities in the Rehabilitation of Peripheral Nerve Injuries: State of the Literature and Current Clinical Applications.

Muscle & nerve·2026
See all related articles

Hereditary glycogen storage diseases cause muscle weakness and exercise intolerance. Research is advancing molecular understanding and exploring new treatments like gene therapy for these complex genetic disorders.

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • 11 hereditary disorders of glycogen metabolism affect muscle, causing exercise intolerance or progressive weakness.
  • These disorders exhibit significant genetic heterogeneity.
  • Pathophysiological mechanisms of muscle breakdown and weakness are not fully understood.

Purpose of the Study:

  • To summarize the current understanding of hereditary glycogen storage diseases.
  • To highlight recent advances in molecular and biochemical insights.
  • To discuss ongoing research into pathogenesis and therapeutic strategies.

Main Methods:

  • Review of existing literature on glycogen storage diseases.
  • Analysis of molecular and genetic findings.

Related Experiment Videos

  • Discussion of pathophysiological mechanisms and therapeutic developments.

    • Main Results:

    • Significant progress in understanding the molecular basis of glycogen storage diseases.
    • Discovery of new biochemical defects, particularly in the glycolytic pathway.
    • Clarification of polyglucosan deposition in various disorders.

    Conclusions:

    • Hereditary glycogen storage diseases present diverse clinical syndromes.
    • Continued research is revealing new biochemical defects and clarifying disease pathogenesis.
    • Gene therapy and enzyme replacement are promising future treatments.